XML 30 R7.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
6 Months Ended 37 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Cash flows from operating activities:      
Net income (loss) $ 46,557 $ (31,040) $ (46,878)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 5,421 2,408 16,268
Accretion of asset retirement obligation 474 479 2,642
Deferred income tax benefit (13,481)   (13,481)
Non-cash inventory write-downs 1,585 915 23,602
Non-cash share-based compensation expense 3,386 15,133 32,516
Impairment of fixed assets     3,114
Other operating adjustments (113) 13 (170)
Increase (decrease) in cash, excluding the effects of acquisitions and dispositions, resulting from changes in:      
Accounts receivable (20,711) 444 (37,683)
Inventory (12,593) (366) (36,462)
Prepaid expenses and other (417) (994) (1,440)
Accounts payable 14,194 1,489 18,379
Asset retirement obligation (339) (304) (1,358)
Accrued expenses 7,395 (2,931) 13,881
Net cash provided by/(used in) operating activities 31,358 (14,754) (27,070)
Cash flows from investing activities:      
Acquisition of the Mountain Pass facility     (82,150)
Cash paid in connection with acquisitions, net of cash acquired (20,021)   (20,021)
Proceeds from sale of investment in joint venture     9,700
Deposits 10,700   (15,500)
Capital expenditures (79,291) (7,260) (120,026)
Other assets (33)   (144)
Proceeds from sale of assets   9 14
Net cash used in investing activities (88,645) (7,251) (228,127)
Cash flows provided by financing activities:      
Capital contributions from original stockholders   15,000 125,004
Repayments of short-term borrowings - related party (1,688)   (2,795)
Repayments of debt (2,958)   (2,958)
Net proceeds from sale of common stock in conjunction with the initial public offering     378,633
Net proceeds from sale of preferred stock 199,642   199,642
Net proceeds from sale of convertible notes 223,100   223,100
Payment of financing costs (22)   (207)
Payment of preferred dividends (3,320)   (3,320)
Proceeds from exercise of stock options   300 350
Proceeds from short-term borrowings - related party   5,008 11,645
Proceeds from debt 6,288   6,288
Net cash provided by financing activities 421,042 20,308 935,382
Effect of exchange rate changes on cash 97   97
Net change in cash and cash equivalents 363,852 (1,697) 680,282
Cash and cash equivalents at beginning of the period 316,430 6,929  
Cash and cash equivalents at end of period 680,282 5,232 680,282
Supplemental disclosure of non-cash activities:      
Change in accrued capital expenditures 34,540 1,126  
Net cash paid for taxes $ 505   $ 0